Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis.A letter to the editor is presented in response to the article "A Comparison of Subcutaneous Low-Molecular-Weight Heparin With Warfarin Sodium for Prophylaxis Against Deep-Vein Thrombosis After Hip or Knee ...
Heparin/warfarin 来自 Springer 喜欢 0 阅读量: 7 摘要: An event is serious (FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage A 64-year-old woman developed heparin-...
An argument can be made to use heparin and subsequently warfarin during the 3- to 6-week period during which further thrombus development and embolization is a concern. The other aspect of the decision regarding acute anticoagulation relates to the risk of bleeding into the brain or other organs...
North American Fragmin Trial Investigators, Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. Arch Intern Med. 2000;1602199- 2207ArticleGoogle ScholarCrossref 46. Rabinov KPaulin S ...
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin: Assessment of a Standardized Periprocedural Anticoagulation Regimen BACKGROUND: The treatment of patients at increased risk for arterial thromboembolism who require temporary interruption of warfarin sodium therapy is a com...
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomize... Based on the current understanding that venous thrombosis starts perioperatively, administration of just-in-time low-molecular-weight heparin ...
Background The disturbance in the international normalized ratio (INR) in patients receiving warfarin therapy is of concern. We aimed to evaluate coagulati... N Omidi,SK Forouzannia,H Poorhosseini,... - 《Journal of Cardiac Surgery》 被引量: 0发表: 2020年 Lean Six Sigma in healthcare: Fas...
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin: Assessment of a Standardized Periprocedural Anticoagulation Regimen BACKGROUND: The treatment of patients at increased risk for arterial thromboembolism who require temporary interruption of warfarin sodium therapy is a com...
A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis It has been shown that several different low molecular weight (LMW) heparins, given by a once- or twice-daily subcutaneous injection without laborator...
Background: The continuation of long-term warfarin therapy is gaining acceptance in minor surgeries but maintaining therapeutic international normalized ra... MG Johnston,MA Porter,KE Eppich,... - 《Orthopedics》 被引量: 0发表: 2024年 Deep vein thrombosis prevention in joint arthroplasties: continuou...